FINANCIAL STATEMENT ANALYSIS

USED BY US DEPARTMEN OF EDUCATION, UNIVERSITIES, STUDENTS & ACCOUNTING PRO'S

VentureLine tracks and provides 5-year financial statement analysis on approximately 7,000+ publicly traded companies; the SEC-traceable data is updated weekly. For your convenience you can access that current company financial statement analysis information by clicking directly on the Company Name, visit their Website or enter the Company name or Ticker symbol, e.g. enter 'Microsoft' or 'MSFT' for Microsoft, in the Company Search window below.

FINANCIAL STATEMENT ANALYSIS UPDATED: JULY 5, 2020

Results 201 through 217 of 217

PHARMACEUTICAL PREPARATIONS - SIC # 2834

Ticker Exchange Company Financial Reports SIC #
TORC Nasdaq resTORbio, Inc. 2834
TRVI Nasdaq Trevi Therapeutics Inc 2834
TTNP Nasdaq Titan Pharmaceuticals, Inc. 2834
TXMD Nasdaq TherapeuticsMD Inc 2834
UMRX Nasdaq Unum Therapeutics Inc 2834
VERU Nasdaq Veru Inc 2834
VNDA Nasdaq Vanda Pharmaceuticals Inc. 2834
VRCA Nasdaq Verrica Pharmaceuticals Inc 2834
VRTX Nasdaq Vertex Pharmaceuticals Incorpo 2834
VSTM Nasdaq Verastem Inc 2834
VTVT Nasdaq vTv Therapeutics Inc 2834
VVUS Nasdaq VIVUS, Inc. 2834
XENE Nasdaq Xenon Pharmaceuticals Inc 2834
XNCR Nasdaq Xencor Inc 2834
XOMA Nasdaq XOMA Corp 2834
ZGNX Nasdaq Zogenix, Inc. 2834
ZTS New York Zoetis Inc 2834
Results 200 through 217 of 217